Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

A Big Chalk Analytics survey of 4,511 U.S. shoppers in spring of 2025 showed that 11.2% of adults are using GLP-1 drugs, and ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema.

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...

For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

HealthDay News — Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study ...

CHICAGO — Tariffs, the rise of GLP-1 medications and concerns about ultra-processed foods (UPFs) remain some of the major ...

For older patients with cancer and T2D, GLP-1 RA use is associated with lower all-cause mortality than DPP4i use.

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.